Precision therapeutics uses

Empowering precision therapeutics with comprehensive genomic insights

Partner with us to gain the most complete view of the genetics of your disease of interest to drive informed decision-making throughout the entire drug development life cycle.

9.5 Million
Publications Indexed
6,500
Genes Curated
9,000
Gene-Disease Relationships Curated

Leverage our expertise to build a complete, reliable foundation of evidence prior to entering the most expensive and time-consuming phases of drug development.

Target and Indication Selection

Enhance your confidence in the targets and indications you select with customizable, thorough reports that answer your most pressing questions, including the extent of existing preclinical work, the characteristics of your target patient population, and more.

Indication Expansion

Expand indications for existing targeted therapeutics based on complete evidence with a customizable, thorough evaluation of the applicable pathway, mechanism, related indications, and more.

Market Assessment

Genomenon’s evidence-based disease prevalence estimates inform market assessment. This data helps pharmaceutical companies understand the patient population and potential market size.

Leverage our expertise and leading software to ensure rapid access to the evidence you need to progress your program through clinical development.

Trial Eligibility and CDx

Expand and refine your inclusion criteria and companion diagnostics, and speed trial enrollment through rapid access to complete genetic evidence.

Genotype-Phenotype Analysis

Strengthen your understanding of genotype-phenotype correlations and enhance your trial design with complete knowledge of published patients alongside their demographics, clinical presentation, and full genotype.

Diagnostic Yield and Awareness

Enhance diagnostic yield and awareness of your disease of interest by granting our network of 2000+ clinical labs access to expertly-curated evidence that accelerates and ensures the completeness of genetic test results.

Genetic Disease Sponsorship - Leverage our expansive network to enhance diagnostic yield and continue to build awareness, even beyond approval.

Enhance Diagnostic Yield and Awareness

Enhance diagnostic yield and awareness of your disease of interest by granting our network of 2,000+ clinical labs access to expertly-curated evidence that accelerates and ensures the completeness of genetic test results.

Research & Development
Preclinical & Phase 1
Phase 2-3
Post Market

Impacting Top Research Institutions and Hospitals

Case Study

Understanding the Comprehensive Variant Landscape of Rare Obesity Disorders

Read the Case Study
Webinar

It Takes a Village: Developing Treatments for Rare Disease

Watch the recording
Webinar

Rare Perspectives Roundtable: The End of VUS? Impact on Diagnosis and Treatment of Rare Diseases

Watch the recording

Our Offerings For Precision Therapeutics

Precision Therapeutics Services

Our expert team provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.

Software

A cutting-edge software tool, Mastermind leverages AI to analyze and interpret vast genomic datasets, offering unparalleled insights.

Somatic Knowledgebase

Empower your team to interpret complex cancer genomic profiles. Our somatic software and data resources save time and find valuable information that connects cancer variants to therapies and clinical trials.

Data

Explore our extensive collection of meticulously curated genomic information. Our database offers detailed insights at both the gene and variant levels, complemented by a fully indexed system for efficient variant data retrieval.

Find out how we can help your organization.